Diagnostic Discrepancy & Mass Progression Tracker

Clinical Scenario Presets:

Clinical Timeline & Scans

3 Milestones

Add Imaging or Clinical Milestone

Date

Modality / Source

Max Diameter (cm)

Reported Impression

Radiologic Fat Density / CT Attenuation

Reported Symptoms (comma separated)

Physician Remarks / Surveillance Recommendation

Growth Rate -- Linear velocity

Volume Doubling Time -- Exponential trajectory

Discrepancy Index -- Red flag criteria

Clinical Action -- Recommended path

Volumetric & Linear Growth Trajectory vs. Benign Baseline

Observed Trajectory

Typical Benign Threshold (AML < 0.25 cm/yr)

Month 0 Hover over nodes on canvas to inspect exact scan parameters Surveillance End

Diagnostic Discordance Analysis: Initial Label vs. Observed Course

High Discordance

Presumed Benign Angiomyolipoma (AML)

✓ Growth: Typically indolent or quiescent (<0.25 cm/year in non-tuberous sclerosis cases).
✓ Imaging Attenuation: Hallmark presence of macroscopic fat (-20 to -80 Hounsfield Units) on non-contrast CT.
✓ Clinical Presentation: Mostly asymptomatic incidental finding; acute pain usually only triggers if intra-tumoral aneurysm bleeds.

Discordant Red Flags Observed

Specialist Consultation Dossier: Targeted Second-Opinion Questions

When a presumed benign mass shows persistent growth, increasing pain, or clothes no longer fitting, take these targeted questions to a tertiary sarcoma or surgical oncology specialist:

Clinical model active. 3 milestones parsed.

Clinical Context: Why Presumed Benign Masses Get Misdiagnosed (Angiomyolipoma vs. Retroperitoneal Sarcoma)

The Diagnostic Challenge

Retroperitoneal sarcomas (such as well-differentiated or dedifferentiated liposarcomas) and renal angiomyolipomas can share overlapping radiologic appearances because both contain varying proportions of fat and soft tissue. When an initial radiologist identifies lipid density, they may prematurely anchor on a benign angiomyolipoma.

The "Buttoning Pants" Warning

In the reported clinical case of Maria Morales, progressive abdominal girth ("couldn't button her pants"), persistent fatigue, and deep back pain over 4 months were key clinical signals that contradicted an indolent benign mass. Retroperitoneal compartments allow tumors to expand to massive volumes before organ compression produces jaundice or bowel obstruction.

When to Demand Core Biopsy & Multidisciplinary Review

If a mass exceeds 4 cm, shows a doubling time under 6 months, lacks macroscopic fat on re-review, or is accompanied by persistent pain, guidelines recommend referral to a dedicated high-volume sarcoma tumor board rather than passive observation in primary care.